Engineering Superior Treatments for Patients with Life-Threatening and Function-Threatening Diseases
About Valitor
Valitor’s technology enables us to engineer BioBetter products with previously unattainable pharmacological properties to maximize clinical impact
Our technology
Our core technology platform originated at UC Berkeley and enables us to generate multivalent protein (MVP) conjugates by tethering multiple copies of bioactive molecules (e.g., camelid antibodies, cytokines, etc.) to single-chain, soluble biopolymers. Using Valitor’s propriety compositions and chemistry methods, our MVPs exhibit the following advantages over other therapeutic products that are either on the market or in development:
Proteins / peptides
Antibodies / Fabs
Nucleotides
Small molecules
Multivalent Polymer
“MVP” Conjugation
BioBetter features of MVP conjugates:
Extended Target Tissue Retention
Superior Pharmacokinetics
Protection from Deactivation
Engineered for
High Potency
Designed using
Endogenous Materials
Superior Pharmaco-stability
Superior Pharmacodynamics
Superior Safety Profile
Awards
Semi finalist 2011
California JumpStart Award 2016
Investors
Contact Us
Valitor, Inc.
East Bay Innovation Center
820 Heinz Avenue
Berkeley, CA 94710
Phone: (510) 545-6062
Fax: (510) 647-8429
Email: info@valitorbio.com
Please download our preview slide deck
for additional information about Valitor